Literature DB >> 32164190

Translating Translation to Mechanisms of Cardiac Hypertrophy.

Michael J Zeitz1, James W Smyth1,2,3.   

Abstract

Cardiac hypertrophy in response to chronic pathological stress is a common feature occurring with many forms of heart disease. This pathological hypertrophic growth increases the risk for arrhythmias and subsequent heart failure. While several factors promoting cardiac hypertrophy are known, the molecular mechanisms governing the progression to heart failure are incompletely understood. Recent studies on altered translational regulation during pathological cardiac hypertrophy are contributing to our understanding of disease progression. In this brief review, we describe how the translational machinery is modulated for enhanced global and transcript selective protein synthesis, and how alternative modes of translation contribute to the disease state. Attempts at controlling translational output through targeting of mTOR and its regulatory components are detailed, as well as recently emerging targets for pre-clinical investigation.

Entities:  

Keywords:  connexin43; hypertrophy; mTOR; translation

Year:  2020        PMID: 32164190     DOI: 10.3390/jcdd7010009

Source DB:  PubMed          Journal:  J Cardiovasc Dev Dis        ISSN: 2308-3425


  8 in total

1.  METTL3 mediates Ang-II-induced cardiac hypertrophy through accelerating pri-miR-221/222 maturation in an m6A-dependent manner.

Authors:  Rui Zhang; Yangyang Qu; Zhenjun Ji; Chunshu Hao; Yamin Su; Yuyu Yao; Wenjie Zuo; Xi Chen; Mingming Yang; Genshan Ma
Journal:  Cell Mol Biol Lett       Date:  2022-07-14       Impact factor: 8.702

Review 2.  Cardiotoxicity and Heart Failure: Lessons from Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Anticancer Drugs.

Authors:  Agapios Sachinidis
Journal:  Cells       Date:  2020-04-17       Impact factor: 6.600

Review 3.  Translation Regulation by eIF2α Phosphorylation and mTORC1 Signaling Pathways in Non-Communicable Diseases (NCDs).

Authors:  Tiffany J Rios-Fuller; Melanie Mahe; Beth Walters; Dounia Abbadi; Sandra Pérez-Baos; Abhilash Gadi; John J Andrews; Olga Katsara; C Theresa Vincent; Robert J Schneider
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

4.  Mass Spectrometry-Based Redox and Protein Profiling of Failing Human Hearts.

Authors:  Tamara Tomin; Matthias Schittmayer; Simon Sedej; Heiko Bugger; Johannes Gollmer; Sophie Honeder; Barbara Darnhofer; Laura Liesinger; Andreas Zuckermann; Peter P Rainer; Ruth Birner-Gruenberger
Journal:  Int J Mol Sci       Date:  2021-02-11       Impact factor: 6.208

5.  Ginkgolide B Protects Cardiomyocytes from Angiotensin II-Induced Hypertrophy via Regulation of Autophagy through SIRT1-FoxO1.

Authors:  Qingyuan Jiang; Ming Lu; Jinyu Li; Zhongsheng Zhu
Journal:  Cardiovasc Ther       Date:  2021-06-23       Impact factor: 3.023

Review 6.  The function of LncRNA-H19 in cardiac hypertrophy.

Authors:  Wenhua Su; Qian Huo; Hao Wu; Lulin Wang; Xiaoxue Ding; Liwen Liang; Liang Zhou; Yan Zhao; Juhua Dan; Hong Zhang
Journal:  Cell Biosci       Date:  2021-08-03       Impact factor: 7.133

Review 7.  Therapeutic Potential of Emerging NAD+-Increasing Strategies for Cardiovascular Diseases.

Authors:  Noemi Rotllan; Mercedes Camacho; Mireia Tondo; Elena M G Diarte-Añazco; Marina Canyelles; Karen Alejandra Méndez-Lara; Sonia Benitez; Núria Alonso; Didac Mauricio; Joan Carles Escolà-Gil; Francisco Blanco-Vaca; Josep Julve
Journal:  Antioxidants (Basel)       Date:  2021-12-03

8.  Nicotinamide Riboside Alleviates Cardiac Dysfunction and Remodeling in Pressure Overload Cardiac Hypertrophy.

Authors:  Sai Ma; Jing Feng; Xiuyu Lin; Jing Liu; Yi Tang; Shinan Nie; Jianbin Gong; Lei Wang
Journal:  Oxid Med Cell Longev       Date:  2021-09-15       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.